PharmaEssentia (LUX:PHECR) E10: $-0.03 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUX:PHECR PharmaEssentia Corp LUX:PHECR
82 GF Score
Price $8.67
GF Value $8.82
! 1 Warning Sign
View Full Analysis

What is PharmaEssentia E10?

PharmaEssentia LUX:PHECR 82 E10 is $-0.03 as of Mar. 2026. GuruFocus rates LUX:PHECR with a GF Score™ of 82/100 and a GF Value™ of $8.82. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PharmaEssentia's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.163. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.03 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-29), PharmaEssentia's current stock price is $8.66667. PharmaEssentia's E10 for the quarter that ended in Mar. 2026 was $-0.03. PharmaEssentia's Shiller PE Ratio of today is .


PharmaEssentia  (LUX:PHECR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PharmaEssentia E10 Related Terms


PharmaEssentia E10 Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia E10 Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.09 -0.07 -0.05

PharmaEssentia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.06 -0.05 -0.05 -0.03

LUX:PHECR vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEssentia Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's Shiller PE Ratio falls into.


LUX:PHECR
82GF Score
PharmaEssentia Corp LUX:PHECR
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaEssentia's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.163/330.2130*330.2130
=0.163

Current CPI (Mar. 2026) = 330.2130.

PharmaEssentia Quarterly Data

per share eps CPI Adj_EPS
201606 -0.026 241.018 -0.036
201609 -0.027 241.428 -0.037
201612 -0.027 241.432 -0.037
201703 -0.027 243.801 -0.037
201706 -0.025 244.955 -0.034
201709 -0.023 246.819 -0.031
201712 -0.030 246.524 -0.040
201803 -0.029 249.554 -0.038
201806 -0.025 251.989 -0.033
201809 -0.029 252.439 -0.038
201812 -0.042 251.233 -0.055
201903 -0.033 254.202 -0.043
201906 -0.023 256.143 -0.030
201909 -0.033 256.759 -0.042
201912 -0.011 256.974 -0.014
202003 -0.035 258.115 -0.045
202006 -0.025 257.797 -0.032
202009 -0.066 260.280 -0.084
202012 -0.094 260.474 -0.119
202103 -0.075 264.877 -0.093
202106 -0.060 271.696 -0.073
202109 -0.079 274.310 -0.095
202112 -0.099 278.802 -0.117
202203 -0.056 287.504 -0.064
202206 -0.027 296.311 -0.030
202209 -0.037 296.808 -0.041
202212 -0.013 296.797 -0.014
202303 -0.065 301.836 -0.071
202306 -0.016 305.109 -0.017
202309 0.017 307.789 0.018
202312 0.010 306.746 0.011
202403 0.025 312.332 0.026
202406 0.052 314.175 0.055
202409 0.056 315.301 0.059
202412 0.092 315.605 0.096
202503 0.093 319.799 0.096
202506 0.068 322.561 0.070
202509 0.118 324.800 0.120
202512 0.114 324.054 0.116
202603 0.163 330.213 0.163

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.03 mean?
PharmaEssentia (LUX:PHECR) has a E10 of $-0.03 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's E10 too high?
PharmaEssentia's current E10 is $-0.03. Overall, PharmaEssentia has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's E10 compare to ZTS?
PharmaEssentia's E10 of $-0.03 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current E10 is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
PharmaEssentia (LUX:PHECR) has a current E10 of $-0.03. The stock's GF Value™ is $8.82, compared to a current price of $8.67 — trading 1.7% below its estimated fair value. The current E10 is $-0.03. PharmaEssentia's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For PharmaEssentia (LUX:PHECR), the current E10 is $-0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (LUX:PHECR) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be undervalued. The current stock price of $8.67 is trading 1.7% below its estimated GF Value™ of $8.82.

Key valuation signals for LUX:PHECR:

  • E10: $-0.03
  • GF Value™: $8.82 vs. price of $8.67 (1.7% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the LUX:PHECR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaEssentia Business Description

Other Exchanges 6446:Taiwan
Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
82GF Score

Get the complete analysis for LUX:PHECR

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.67
Price
$8.82
GF Value